Follow
Nikolaos Dietis
Nikolaos Dietis
Pharmacologist, Medical School University of Cyprus
Verified email at ucy.ac.cy - Homepage
Title
Cited by
Cited by
Year
Opioid receptor subtypes: fact or artifact?
N Dietis, DJ Rowbotham, DG Lambert
British journal of anaesthesia 107 (1), 8-18, 2011
1982011
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile
N Dietis, R Guerrini, G Calo, S Salvadori, DJ Rowbotham, DG Lambert
British journal of anaesthesia 103 (1), 38-49, 2009
1942009
Opioid analgesia and opioid-induced adverse effects: A review
AK Paul, CM Smith, M Rahmatullah, V Nissapatorn, P Wilairatana, ...
Pharmaceuticals 14 (11), 1091, 2021
912021
Stress-based animal models of depression: Do we actually know what we are doing?
X Yin, N Guven, N Dietis
Brain Research 1652, 30-42, 2016
822016
Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells
Y Gregoriou, G Gregoriou, V Yilmaz, K Kapnisis, M Prokopi, A Anayiotos, ...
Nanotheranostics 5 (1), 113, 2021
602021
Ways to increase adherence to allergen immunotherapy
C Pitsios, N Dietis
Current Medical Research and Opinion 35 (6), 1027-1031, 2019
412019
Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19
M Tomazou, M Bourdakou, G Minadakis, M Zachariou, A Oulas, ...
252021
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP‐505
N Dietis, H Niwa, R Tose, J McDonald, V Ruggieri, M Filaferro, G Vitale, ...
British journal of pharmacology 175 (14), 2881-2896, 2018
232018
Morphine dosing strategy plays a key role in the generation and duration of the produced antinociceptive tolerance
AK Paul, N Gueven, N Dietis
Neuropharmacology 121, 158-166, 2017
212017
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505)
N Dietis, J McDonald, S Molinari, G Calo, R Guerrini, DJ Rowbotham, ...
British journal of anaesthesia 108 (2), 262-270, 2012
192012
A novel conjugate of bis [((4-bromophenyl) amino) quinazoline], a EGFR-TK ligand, with a fluorescent Ru (II)-bipyridine complex exhibits specific subcellular localization in …
R Ilmi, E Tseriotou, P Stylianou, YA Christou, I Ttofi, N Dietis, C Pitris, ...
Molecular Pharmaceutics 16 (10), 4260-4273, 2019
172019
Computational drug repurposing for neurodegenerative diseases
K Savva, M Zachariou, A Oulas, G Minadakis, K Sokratous, N Dietis, ...
In Silico Drug Design, 85-118, 2019
162019
Profiling the effects of repetitive morphine administration on motor behavior in rats
AK Paul, N Gueven, N Dietis
Molecules 26 (14), 4355, 2021
142021
Network-based stage-specific drug repurposing for Alzheimer’s disease
K Savva, M Zachariou, MM Bourdakou, N Dietis, GM Spyrou
Computational and Structural Biotechnology Journal 20, 1427-1438, 2022
102022
Age-dependent antinociception and behavioral inhibition by morphine
AK Paul, N Gueven, N Dietis
Pharmacology Biochemistry and Behavior 168, 8-16, 2018
92018
Opioid receptor-dependent modulation of insulin-release in pancreatic beta-cells
A Paul, N Guven, N Dietis
Pharmaceutical and Biosciences Journal, 22-31, 2014
82014
Gaps in knowledge about SARS-CoV-2 & COVID-19 among university students are associated with negative attitudes toward people with COVID-19: a cross-sectional study in Cyprus
N Middleton, C Tsioutis, O Kolokotroni, A Heraclides, ...
Frontiers in public health 9, 758030, 2021
62021
Strategies to reduce morphine tolerance in cancer: evaluation of the bifunctional opioid UFP-505
N Dietis
University of Leicester, 2012
52012
Data on prolonged morphine-induced antinociception and behavioral inhibition in older rats
AK Paul, N Gueven, N Dietis
Data in Brief 19, 183-188, 2018
42018
Opioids in depression: not quite there yet
X Yin, N Guven, N Dietis
Pharmaceutical and Biosciences Journal, 12-17, 2015
42015
The system can't perform the operation now. Try again later.
Articles 1–20